Link between insulin resistance and hypertension: What is the evidence from evolutionary biology?

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Zhou, Ming Sheng ^a   Wang, Aimei ^a   Yu, Hong ^b  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Evolution; Hypertension; Inflammation and sodium; Insulin resistance

Indexed keywords

INSULIN; SODIUM;

BIOLOGY; BLOOD PRESSURE; DISEASE ASSOCIATION; EVOLUTION; EVOLUTIONARY BIOLOGY; HUMAN; HYPERTENSION; HYPOTHESIS; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SURVIVAL;

EID: 84893178599     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-12     Document Type: Review

References (61)

1. Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases. Schulman IH, Zhou MS, Curr Hypertens Rep 2009 11 48 55 10.1007/s11906-009-0010-0 19146801
2. Circulatory syndrome: an evolution of the metabolic syndrome concept! Khoshdel AR, Carney SL, Gillies A, Curr Cardiol Rev 2012 8 68 76 10.2174/157340312801215773 22845817
3. Insulin resistance and cardiovascular disease. Ginsberg HN, J Clin Invest 2000 106 453 458 10.1172/JCI10762 10953019
4. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease. Zhou MS, Schulman IH, Zeng Q, Vasc Med 2012 17 330 341 10.1177/1358863X12450094 22814999
5. Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. Lastra G, Dhuper S, Johnson MS, Sowers JR, Nat Rev Cardiol 2010 7 577 584 10.1038/nrcardio.2010.123 20697411
6. Nitric oxide release accounts for insulin's vascular effects in humans. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P, J Clin Invest 1994 94 2511 2515 10.1172/JCI117621 7989610
7. Chronic sodium-retaining action of insulin in diabetic dogs. Manhiani MM, Cormican MT, Brands MW, Am J Physiol Renal Physiol 2011 300 957 F965 10.1152/ajprenal.00395.2010 21228110
8. Insulin resistance, obesity, hypertension, and renal sodium transport. Horita S, Seki G, Yamada H, Suzuki M, Koike K, Fujita T, Int J Hypertens 2011 2011 391762 21629870
9. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C, Stas S, Sowers JR, Am J Physiol Heart Circ Physiol 2007 293 2009 H2023 10.1152/ajpheart.00522.2007 17586614
10. Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment-an evolutionary perspective. Tsatsoulis A, Mantzaris MD, Bellou S, Andrikoula M, Metabolism 2013 62 622 633 10.1016/j.metabol.2012.11.004 23260798
11. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Johnson AR, Milner JJ, Makowski L, Immunol Rev 2012 249 218 238 10.1111/j.1600-065X.2012.01151.x 22889225
12. The evolutionary benefit of insulin resistance. Soeters MR, Soeters PB, Clin Nutr 2012 31 1002 1007 10.1016/j.clnu.2012.05.011 22682085
13. Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation. Soeters MR, Soeters PB, Schooneman MG, Houten SM, Romijn JA, Am J Physiol Endocrinol Metab 2012 303 1397 E1407 10.1152/ajpendo.00397.2012 23074240
14. Ethnic variability in adiposity, thrifty phenotypes and cardiometabolic risk: addressing the full range of ethnicity, including those of mixed ethnicity. Wells JC, Obes Rev 2012 13 Suppl 2 14 29 23107256
15. Cardiovascular actions of insulin. Muniyappa R, Montagnani M, Koh KK, Quon MJ, Endocr Rev 2007 28 463 491 10.1210/er.2007-0006 17525361
16. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. Zhou MS, Schulman IH, Raij L, J Hypertens 2010 28 527 535 10.1097/HJH. 0b013e3283340da8 19898250
17. Effects of dietary composition on energy expenditure during weight-loss maintenance. Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS, JAMA 2012 307 2627 2634 22735432
18. Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context. Ruiz-Nunez B, Pruimboom L, Dijck-Brouwer DA, Muskiet FA, J Nutr Biochem 2013 24 1183 1201 10.1016/j.jnutbio.2013.02.009 23657158
19. Adaptive immunity in obesity and insulin resistance. Sell H, Habich C, Eckel J, Nat Rev Endocrinol 2012 8 709 716 10.1038/nrendo.2012.114 22847239
20. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance. Murdolo G, Piroddi M, Luchetti F, Tortoioli C, Canonico B, Zerbinati C, Galli F, Iuliano L, Biochimie 2013 95 585 594 10.1016/j.biochi.2012.12.014 23274128
21. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Kahn SE, Hull RL, Utzschneider KM, Nature 2006 444 840 846 10.1038/nature05482 17167471
22. Inflammatory links between obesity and metabolic disease. Lumeng CN, Saltiel AR, J Clin Invest 2011 121 2111 2117 10.1172/JCI57132 21633179
23. Reduced adipose tissue macrophage content is associated with improved insulin sensitivity in thiazolidinedione-treated diabetic humans. Koppaka S, Kehlenbrink S, Carey M, Li W, Sanchez E, Lee DE, Lee H, Chen J, Carrasco E, Kishore P, Zhang K, Hawkins M, Diabetes 2013 62 1843 1854 10.2337/db12-0868 23349486
24. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Lumeng CN, Bodzin JL, Saltiel AR, J Clin Invest 2007 117 175 184 10.1172/JCI29881 17200717
25. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H, J Clin Invest 2003 112 1821 1830 10.1172/JCI200319451 14679177
26. Inflammation and insulin resistance. Shoelson SE, Lee J, Goldfine AB, J Clin Invest 2006 116 1793 1801 10.1172/JCI29069 16823477
27. Immune regulation and vascular inflammation in genetic hypertension. Viel EC, Lemarie CA, Benkirane K, Paradis P, Schiffrin EL, Am J Physiol Heart Circ Physiol 2010 298 938 H944 10.1152/ajpheart.00707.2009 20044442
28. Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension. Zhou MS, Schulman IH, Raij L, Am J Physiol Heart Circ Physiol 2009 296 833 H839 10.1152/ajpheart.01096.2008 19151253
29. Pasteur's Quadrant and malnutrition. Blackburn GL, Nature 2001 409 397 401 10.1038/35053187 11201754
30. Concepts of evolutionary medicine and energy regulation contribute to the etiology of systemic chronic inflammatory diseases. Straub RH, Brain Behav Immun 2011 25 1 5 10.1016/j.bbi.2010.08.002 20705130
31. Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. Chandra RK, Proc Natl Acad Sci USA 1996 93 14304 14307 10.1073/pnas.93.25.14304 8962043
32. Inflammation, stress, and diabetes. Wellen KE, Hotamisligil GS, J Clin Invest 2005 115 1111 1119 10.1172/JCI200525102 15864338
33. Energy metabolism and rheumatic diseases: from cell to organism. Spies CM, Straub RH, Buttgereit F, Arthritis Res Ther 2012 14 216 10.1186/ar3885 22747923
34. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C, Mathis D, Nature 2012 486 549 553 22722857
35. Innate immunity, insulin resistance and type 2 diabetes. Fernandez-Real JM, Pickup JC, Diabetologia 2012 55 273 278 10.1007/s00125-011-2387-y 22124608
36. Leptin as an immunomodulator. Procaccini C, Jirillo E, Matarese G, Mol Aspects Med 2012 33 35 45 10.1016/j.mam.2011.10.012 22040697
37. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. Straub RH, Cutolo M, Buttgereit F, Pongratz G, J Intern Med 2010 267 543 560 10.1111/j.1365-2796.2010.02218.x 20210843
38. Insulin resistance: a chicken that has come to roost. Reaven GM, Ann NY Acad Sci 1999 892 45 57 10.1111/j.1749-6632.1999.tb07784.x 10842651
39. An evolutionary framework for common diseases: the ancestral- susceptibility model. Di Rienzo A, Hudson RR, Trends Genet 2005 21 596 601 10.1016/j.tig.2005.08.007 16153740
40. Evolutionary medicine and chronic inflammatory state-known and new concepts in pathophysiology. Straub RH, J Mol Med (Berl) 2012 90 523 534 10.1007/s00109-012-0861-8 22271169
41. The cellular and signaling networks linking the immune system and metabolism in disease. Osborn O, Olefsky JM, Nat Med 2012 18 363 374 10.1038/nm.2627 22395709
42. Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. Straub RH, Besedovsky HO, FASEB J 2003 17 2176 2183 10.1096/fj.03-0433hyp 14656978
43. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Brown NJ, Nat Rev Nephrol 2013 9 459 469 10.1038/nrneph.2013.110 23774812
44. Differential predictors of insulin resistance in nondiabetic salt-resistant and salt-sensitive subjects. Laffer CL, Elijovich F, Hypertension 2013 61 707 715 10.1161/HYPERTENSIONAHA.111.00423 23283360
45. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Kim JA, Montagnani M, Koh KK, Quon MJ, Circulation 2006 113 1888 1904 10.1161/CIRCULATIONAHA.105. 563213 16618833
46. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, Chen CS, Chen J, Lu F, Hu D, Rice T, Kelly TN, Hamm LL, Whelton PK, He J, GenSalt Collaborative Research Group, Lancet 2009 373 829 835 10.1016/S0140-6736(09)60144-6 19223069
47. Evolution of blood pressure regulation in humans. Young JH, Curr Hypertens Rep 2007 9 13 18 10.1007/s11906-007-0004-8 17362666
48. Evolution and hypertension. Weder AB, Hypertension 2007 49 260 265 10.1161/01.HYP.0000255165.84684.9d 17190870
49. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S, Am J Hypertens 2011 24 843 853 10.1038/ajh.2011.115 21731062
50. Hypertension in black patients: special issues and considerations. Nesbitt SD, Curr Hypertens Rep 2005 7 244 248 10.1007/s11906-005-0020-5 16061041
51. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J, Nat Med 2009 15 545 552 10.1038/nm.1960 19412173
52. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Machnik A, Dahlmann A, Kopp C, Goss J, Wagner H, van Rooijen N, Eckardt KU, Müller DN, Park JK, Luft FC, Kerjaschki D, Titze J, Hypertension 2010 55 755 761 10.1161/HYPERTENSIONAHA.109.143339 20142563
53. Regulation of ENaC in mice lacking renal insulin receptors in the collecting duct. Pavlov TS, Ilatovskaya DV, Levchenko V, Li L, Ecelbarger CM, Staruschenko A, FASEB J 2013 27 7 2723 2732 10.1096/fj.12-223792 23558339
54. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Sarafidis PA, Bakris GL, Am J Nephrol 2007 27 44 54 10.1159/000098955 17245074
55. Type II diabetes, essential hypertension, and obesity as syndromes of impaired genetic homeostasis: the thrifty genotype hypothesis enters the 21st century. Neel JV, Weder AB, Julius S, Perspect Biol Med 1998 42 44 74 9894356
56. Diabetes mellitus: a thrifty genotype rendered detrimental by progress? Neel JV, Am J Hum Genet 1962 14 353 362 13937884
57. A nonadaptive scenario explaining the genetic predisposition to obesity: the predation release hypothesis. Speakman JR, Cell Metab 2007 6 5 12 10.1016/j.cmet.2007.06.004 17618852
58. Evolutionary origins of insulin resistance: a behavioral switch hypothesis. Watve MG, Yajnik CS, BMC Evol Biol 2007 7 61 10.1186/1471-2148-7-61 17437648
59. The thrifty epigenotype: an acquired and heritable predisposition for obesity and diabetes? Stoger R, Bioessays 2008 30 156 166 10.1002/bies.20700 18197594
60. Thrift: a guide to thrifty genes, thrifty phenotypes and thrifty norms. Wells JC, Int J Obes (Lond) 2009 33 1331 1338 10.1038/ijo.2009.175 19752875
61. The thrifty phenotype: An adaptation in growth or metabolism? Wells JC, Am J Hum Biol 2011 23 65 75 10.1002/ajhb.21100 21082685